Risk of death from recurrent ischemic events after intravenous streptokinase in acute myocardial infarction: results from the Intravenous Streptokinase in Myocardial Infarction (ISAM) Study

MeSH terms

• Clinical Trials as Topic
• Double-Blind Method
• Humans
• Injections, Intravenous
• Myocardial Infarction / drug therapy*
• Myocardial Infarction / mortality
• Prospective Studies
• Recurrence
• Risk
• Streptokinase / administration & dosage
• Streptokinase / therapeutic use*